| SCYX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SCYX shares outstanding history going back to 5/2/2014:
Also see: SCYX Market Cap History SCYX YTD Return |
SCYX Shares Outstanding History — SCYNEXIS Share Count Over Time
As of 5/1/2026 SCYNEXIS has 9.93 million SCYX shares outstanding. Investors often track the SCYX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SCYX share count trends over time, with 51 historical shares outstanding datapoints presented, dating back to 5/2/2014.
| SCYX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SCYX Historical Shares Outstanding: +46.00% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SCYX Stock Price Chart |
| About SCYNEXIS, Inc. |
| SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens, such as Candida and Aspergillus genera, including multidrug-resistant strains, and Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and common mucorales species. We show 51 historical shares outstanding datapoints in our coverage of SCYX's shares outstanding history. Understanding the changing numbers of SCYX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SCYX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SCYX by allowing them to research SCYX shares outstanding history as well as any other stock in our coverage universe. |
| SCYX Current Stock Quote |
Quotes delayed 20 minutes  Free SCYX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SCYX Share Performance |
| Shares Outstanding Peers |
| SCYNEXIS (SCYX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SDC Shares Outstanding History SDGR Shares Outstanding History SEEL Shares Outstanding History SEER Shares Outstanding History SELB Shares Outstanding History SEM Shares Outstanding History SENS Shares Outstanding History SERA Shares Outstanding History SESN Shares Outstanding History SGEN Shares Outstanding History More Healthcare companies » |
SCYX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
